Skip to main content
OpenTrials

Clinical trial condition

Renal Cell Carcinoma

Explore clinical trials studying Renal Cell Carcinoma. Study availability and eligibility vary by location and protocol.

412 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Renal Cell Carcinoma trial results

Completed

Using Virtual Reality (VR) Models for Preoperative Planning

NCT03334344

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • John Wayne Cancer Institute at Providence St. John's Heath Center Santa Monica, California, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • University of North Carolina, Chapel Hill Chapel Hill, North Carolina, United States
View Trial Details
Completed

A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.

NCT00378482

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +38 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Ann Arbor, Michigan, United States
  • Research Site New York, United States
View Trial Details
Completed

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

NCT03752398

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Carcinoma That is Estrogen Receptor, Progesterone Receptor, and Her2 Negative, +95 more
Locations
  • UC San Diego Moores Cancer Center San Diego, California, United States
  • University of Colorado Hospital - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 18 locations
View Trial Details
Completed

Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients

NCT03776123

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +21 more
Locations
  • Korea University Ansan Hospital Ansan, South Korea
  • Hallym University Sacred Heart Hospital Anyang, South Korea
  • DONG-A University Hospital (Site A) Busan, South Korea
  • DONG-A University Hospital (Site B) Busan, South Korea
View all 47 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies

NCT03629756

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • Scottsdale Healthcare Hospitals dba HonorHealth Scottsdale, Arizona, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Rocky Mountain Cancer Centers (Midtown) Denver, Colorado, United States
View all 15 locations
View Trial Details

Related conditions